Explore
Trendline
ATB Therapeutics Appoints Mark Throsby as CEO to Lead Growth Phase
ATB Therapeutics Appoints Mark Throsby as CEO to Lead Growth Phase
Read More
Trendline
Novastra Therapeutics Appoints New CFO Amid Global Clinical Development Efforts
Novastra Therapeutics Appoints New CFO Amid Global Clinical Development Efforts
Read More
Trendline
Orca Bio Appoints Bijan Nejadnik, M.D., as Chief Medical Officer to Drive Clinical Strategy
Orca Bio Appoints Bijan Nejadnik, M.D., as Chief Medical Officer to Drive Clinical Strategy
Read More
Trendline
Novastra Therapeutics Appoints New CFO to Propel Global Clinical Development
Novastra Therapeutics Appoints New CFO to Propel Global Clinical Development
Read More
Trendline
Ajinomoto Foods North America Appoints Dave Gardner as New CEO, Succeeding Hiroshi Kaho
Ajinomoto Foods North America Appoints Dave Gardner as New CEO, Succeeding Hiroshi Kaho
Read More
Trendline
Ajinomoto Foods North America Appoints Dave Gardner as New CEO
Ajinomoto Foods North America Appoints Dave Gardner as New CEO
Read More
Trendline
GenSight Biologics to Discuss Strategic Priorities at General Meeting
GenSight Biologics to Discuss Strategic Priorities at General Meeting
Read More
Trendline
Andelyn Biosciences Launches New Platform for Lentiviral Vector Manufacturing
Andelyn Biosciences Launches New Platform for Lentiviral Vector Manufacturing
Read More
Trendline
TRIANA Biomedicines Appoints Mohan Bala as COO, Expands Scientific Advisory Board
TRIANA Biomedicines Appoints Mohan Bala as COO, Expands Scientific Advisory Board
Read More
Trendline
TRIANA Biomedicines Appoints Mohan Bala as COO to Strengthen Leadership Amid Growth
TRIANA Biomedicines Appoints Mohan Bala as COO to Strengthen Leadership Amid Growth
Read More
Trendline
Ajinomoto Foods North America Appoints Dave Gardner as New CEO Amid Leadership Transition
Ajinomoto Foods North America Appoints Dave Gardner as New CEO Amid Leadership Transition
Read More
Trendline
Turn Therapeutics Appoints Former FDA Commissioner Dr. Stephen M. Hahn as Executive Clinical Lead
Turn Therapeutics Appoints Former FDA Commissioner Dr. Stephen M. Hahn as Executive Clinical Lead
Read More
